ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
Chronic Pain Clinical Trial Pipeline Experiences Momentum: Delveinsight Estimates A Diverse Pipeline Comprising 20+ Companies Working In The Domain
Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic <a target=_blank href= ...
Hosted on MSN12h
Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now?
QIAGEN N.V.’s QGEN long-term business strategy focuses on forming partnerships for the development, commercialization, marketing and distribution of existing and future products. The company sees ...
Pharmaceutical Technology5h
RFK Jr. trumps domestic manufacturing agenda Day 2 of confirmation hearings
During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...
STAT11h
RFK Jr., Trump’s HHS pick, interrogated on vaccine views at second confirmation hearing
RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.
PharmiWeb11h
Hormone Replacement Therapy Market to Grow at a CAGR of 3.50%, Reaching USD 23,729.6 Million by 2034
Hormone Replacement Therapy MarketThe global hormone replacement therapy (HRT) market is poised for steady growth, with a projected compound annual growth rate (CAGR) of 3.5%. From an estimated market ...
Healio15h
Decentralized clinical trials: FDA guidance and the ‘new modus operandi’
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...